Novotech News

31. Novotech Publishes Report On Research Into Endometrial Cancer, A Leading Cause Of Gynecology Malignancy Mortality  6/28/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released a comprehensive research report - Endometrial cancer - Global Clinical Trial Landscape.

32. Novotech Appoints Dr. Ian Braithwaite As Vice President, Global Project Management To Lead World-Class Clinical Program Operations 6/28/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has appointed Dr. Ian Braithwaite as Vice President, Global Project Management.

33. ​​​Antibody-Drug Conjugates Shift The Cancer Treatment Landscape: Novotech Whitepaper Examines Latest Clinical Trial Data 6/28/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has today released a key research whitepaper entitled Antibody-drug conjugates - Global Clinical Trial Landscape.

34. Novotech Announces MOU With Experienced Psychedelics Research Center At The 4^th Annual Psychedelic Therapeutics And Drug Development Conference In Boston 6/24/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has signed an Memorandum of Understanding (MOU) with New Zealand Clinical Research (NZCR).

35. Novotech Launches Dedicated Early Phase Unit For Biotechs Leveraging The Australian And New Zealand Clinical Environment 6/4/2024

    Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, today announced the launch of a dedicated early phase unit focussed on leveraging the unique advantage of Australian and New Zealand (ANZ) for early phase clinical development.

36. Novotech Signs Strategic MOU With Hong Kong-Shenzhen Innovation And Technology Park Limited (HSITPL) 5/31/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, today announced it has signed a Memorandum of Understanding (MOU) with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL).

37. Novotech Appoints Commercial And Clinical Life Sciences Specialist To Head Up Global Drug Development Consulting Team 5/10/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has appointed Scott Schliebner as Vice President and Global Head, Drug Development Consulting (DDC).

38. Novotech Publishes Research Report On Acute Myeloid Leukaemia Clinical Trial Landscape For Clinical Stage Biotechs 4/15/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an expert report, Acute Myeloid Leukaemia - Global Clinical Trial Landscape, offering critical data-backed analysis of the latest developments in Acute Myeloid Leukemia (AML) research.

39. Novotech Publishes Analyst Report On Cystic Fibrosis Clinical Trial Landscape To Inform Biotech Research Planning  4/11/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released a comprehensive research report entitled Cystic Fibrosis - Global Clinical Trial Landscape.

40. Novotech Publishes Duchenne Muscular Dystrophy Landscape Report To Support Biotech Research Planning  3/15/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released today an industry-leading report on Duchenne Muscular Dystrophy (DMD) Clinical Trial Landscape.